Insider Buy/Sell Details for the Healthcare Sector — August 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1668)
INSMED Inc (INSM)
Adsett Roger — Chief Operating Officer
Shares
239,850
Price
$133.27
Total Value
$31.96M
Shares Held After
98,744
% of Holdings
70.8%
Omada Health, Inc. (OMDA)
Cook Steven L. — Chief Financial Officer
Shares
15,235
Price
$25.03
Total Value
$381.35K
Shares Held After
187,209
% of Holdings
7.5%
908 Devices Inc. (MASS)
Knopp Kevin J. — Director
Shares
348
Price
$9.06
Total Value
$3.15K
Shares Held After
732,255
% of Holdings
0.0%
Replimune Group, Inc. (REPL)
Hill Emily Luisa — Chief Financial Officer
Shares
11,448
Price
$12.97
Total Value
$148.48K
Shares Held After
225,108
% of Holdings
4.8%
Heartflow, Inc. (HTFL)
Farquhar John C.M. — Director
Shares
22,562
Price
$28.31
Total Value
$638.73K
Shares Held After
436,280
% of Holdings
4.9%
Claritev Corp (CTEV)
Mintz William B. — SVP, Chief Strategy Officer
Shares
8,431
Price
$34.24
Total Value
$288.68K
Shares Held After
71,195
% of Holdings
10.6%
Axogen, Inc. (AXGN)
Began Marc A — EVP&General Counsel
Shares
67,500
Price
$47.34
Total Value
$3.20M
Shares Held After
50,135
% of Holdings
57.4%
Bicara Therapeutics Inc. (BCAX)
Hyep Ivan — Chief Financial Officer
Shares
12,500
Price
$27.97
Total Value
$349.59K
Shares Held After
129,855
% of Holdings
8.8%
REGENERON PHARMACEUTICALS, INC. (REGN)
Zoghbi Huda Y — Director
Shares
800
Price
$800.00
Total Value
$640.00K
Shares Held After
1,703
% of Holdings
32.0%
biote Corp. (BTMD)
Beer Marc D — Director
Shares
115,950
Price
$1.53
Total Value
$177.40K
Shares Held After
223,744
% of Holdings
51.8%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
10,000
Price
$27.98
Total Value
$279.75K
Shares Held After
362,152
% of Holdings
2.7%
Medpace Holdings, Inc. (MEDP)
Troendle August J. — Director
Shares
5,534
Price
$601.53
Total Value
$3.33M
Shares Held After
633,412
% of Holdings
0.9%
Bicara Therapeutics Inc. (BCAX)
Cohlhepp Ryan — Director
Shares
18,750
Price
$27.98
Total Value
$524.53K
Shares Held After
181,641
% of Holdings
9.4%
Butterfly Network, Inc. (BFLY)
DEVIVO JOSEPH — Director
Shares
68,346
Price
$10.01
Total Value
$684.08K
Shares Held After
7,603,700
% of Holdings
0.9%
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)
Dodd Sheri Louise — Director
Shares
10,978
Price
$29.44
Total Value
$323.24K
Shares Held After
232,907
% of Holdings
4.5%
ZEVRA THERAPEUTICS, INC. (ZVRA)
Watton Corey Michael — Director
Shares
12,300
Price
$11.25
Total Value
$138.38K
Shares Held After
1,800
% of Holdings
87.2%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
4,770
Price
$114.04
Total Value
$543.96K
Shares Held After
3,985
% of Holdings
54.5%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
11,530
Price
$113.18
Total Value
$1.30M
Shares Held After
8,755
% of Holdings
56.8%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
1,031
Price
$114.52
Total Value
$118.07K
Shares Held After
9,755
% of Holdings
9.6%
REGENERON PHARMACEUTICALS, INC. (REGN)
Guarini Kathryn — Director
Shares
400
Price
$800.00
Total Value
$320.00K
Shares Held After
603
% of Holdings
39.9%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
8,370
Price
$46.75
Total Value
$391.28K
Shares Held After
515,066
% of Holdings
1.6%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
14,171
Price
$45.97
Total Value
$651.49K
Shares Held After
523,436
% of Holdings
2.6%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
113,318
Price
$125.16
Total Value
$14.18M
Shares Held After
818,938
% of Holdings
12.2%
NextCure, Inc. (NXTC)
Simcere Zaiming, Inc. — Former 10% Owner
Shares
30,000
Price
$6.16
Total Value
$184.80K
Shares Held After
308,636
% of Holdings
8.9%
Anteris Technologies Global Corp. (AVR)
L1 Capital Pty Ltd — 10% Owner
Shares
251,844
Price
$9.10
Total Value
$2.29M
Shares Held After
5,187,156
% of Holdings
4.6%
ANI PHARMACEUTICALS INC (ANIP)
Gutwerg Ori — SVP, GENERICS
Shares
3,162
Price
$77.00
Total Value
$243.47K
Shares Held After
75,534
% of Holdings
4.0%
Guardant Health, Inc. (GH)
Freeman Chris — Chief Commercial Officer
Shares
17,413
Price
$170.24
Total Value
$2.96M
Shares Held After
65,374
% of Holdings
21.0%
Guardant Health, Inc. (GH)
Freeman Chris — Chief Commercial Officer
Shares
35,364
Price
$169.63
Total Value
$6.00M
Shares Held After
82,787
% of Holdings
29.9%
Guardant Health, Inc. (GH)
Freeman Chris — Chief Commercial Officer
Shares
7,365
Price
$168.79
Total Value
$1.24M
Shares Held After
118,151
% of Holdings
5.9%
Guardant Health, Inc. (GH)
Freeman Chris — Chief Commercial Officer
Shares
3,463
Price
$167.38
Total Value
$579.64K
Shares Held After
125,516
% of Holdings
2.7%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
2,300
Price
$100.14
Total Value
$230.32K
Shares Held After
194,309
% of Holdings
1.2%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
6,017
Price
$99.25
Total Value
$597.19K
Shares Held After
196,609
% of Holdings
3.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
11,683
Price
$98.51
Total Value
$1.15M
Shares Held After
202,626
% of Holdings
5.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Connaughton Bernadette — Director
Shares
1,626
Price
$102.80
Total Value
$167.15K
Shares Held After
40,418
% of Holdings
3.9%
INTUITIVE SURGICAL INC (ISRG)
Ladd Amy L — Director
Shares
400
Price
$379.00
Total Value
$151.60K
Shares Held After
251
% of Holdings
61.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
397
Price
$111.77
Total Value
$44.37K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
470
Price
$111.05
Total Value
$52.19K
Shares Held After
397
% of Holdings
54.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
272
Price
$109.96
Total Value
$29.91K
Shares Held After
867
% of Holdings
23.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
831
Price
$108.95
Total Value
$90.54K
Shares Held After
1,139
% of Holdings
42.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
737
Price
$108.17
Total Value
$79.72K
Shares Held After
1,970
% of Holdings
27.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
70
Price
$107.11
Total Value
$7.50K
Shares Held After
2,707
% of Holdings
2.5%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
700
Price
$111.41
Total Value
$77.99K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
1,000
Price
$110.64
Total Value
$110.64K
Shares Held After
700
% of Holdings
58.8%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
1,800
Price
$109.30
Total Value
$196.74K
Shares Held After
1,700
% of Holdings
51.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
2,800
Price
$108.38
Total Value
$303.46K
Shares Held After
3,500
% of Holdings
44.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
1,450
Price
$107.58
Total Value
$155.99K
Shares Held After
6,300
% of Holdings
18.7%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Veness Adam M — SVP, General Counsel and Sec.
Shares
16,167
Price
$110.38
Total Value
$1.78M
Shares Held After
0
% of Holdings
100.0%
Lyell Immunopharma, Inc. (LYEL)
Seely Lynn — Director
Shares
390
Price
$14.34
Total Value
$5.59K
Shares Held After
73,488
% of Holdings
0.5%
ICON PLC (ICLR)
Balfe Barry Edward — Director
Shares
78
Price
$165.14
Total Value
$12.88K
Shares Held After
4,804
% of Holdings
1.6%
ICON PLC (ICLR)
Balfe Barry Edward — Director
Shares
304
Price
$163.80
Total Value
$49.80K
Shares Held After
4,882
% of Holdings
5.9%
Showing 151–200 of 1668 transactions (page 4 of 34)